$256 million U.S. market opportunity drives expansion as company kicks off multi-channel promotional campaign Scienture Holdings (SCNX) announced the official...
RP1 combined with nivolumab shows meaningful tumor response in rare and aggressive skin cancer Replimune Group (REPL), a clinical-stage biotechnology...
Positive data from Essential3 program marks major step toward first targeted therapy for millions living with essential tremor Praxis Precision...
REQORSA® gene therapy shows promise against hard-to-treat ALK-positive non-small cell lung cancer Clinical-stage gene therapy developer Genprex (GNPX) announced that...
Semiconductor optimism drives bullish calls on AMD and Monolithic Power while managed care stocks come under pressure Wall Street analysts...
Prospective acquisition of Protagonist Therapeutics centers on oral drug for immune diseases Johnson & Johnson (JNJ) is reportedly in active...
Positive early results accelerate timeline and reduce capital needs by up to $15 million Envoy Medical (COCH), a Minnesota-based hearing...
Exemptions for U.S. plant construction and existing expansion plans temper immediate fallout, but uncertainty remains for smaller firms Shares of...
Analysts cite lack of new scientific evidence as shares recover from record low Kenvue (KVUE) shares rose 6% on Tuesday,...
BA-101 aims to address urgent unmet needs in one of the deadliest brain cancers NeuroNOS, a subsidiary of Beyond Air...
© 2024 All Rights Reserved: STOXPO.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information
Do you really wish to opt-out?